162607-26-3Relevant articles and documents
HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF
-
Paragraph 0708; 0711, (2021/02/25)
The present invention relates to a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the treatment of various HAT-related diseases or conditions.
PHOTOCHROMIC COMPOUND, AND REWRITABLE OPTICAL RECORDING MOLECULAR MATERIAL, FLUORESCENCE LABEL MATERIAL, AND SECURITY INK PREPARED THEREWITH
-
Paragraph 0053, (2016/12/01)
PROBLEM TO BE SOLVED: To provide a photochromic molecule showing light emission in both isomers of a ring-opened body and a ring-closed body. SOLUTION: A photochromic compound comprises a photochromism unit having a hexatriene skeleton, and a fluorescence emission unit bound to carbon at a ring-forming position of the hexatriene skeleton of the photochromism unit. SELECTED DRAWING: Figure 3 COPYRIGHT: (C)2016,JPO&INPIT